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Abstract:  Antioxidants  are  among  the  most  popular  health-protecting  products,  sold 
worldwide without prescription. Indeed, there are many reports showing the benefits of 
antioxidants but only a few questioning the possible harmful effects of these ―drugs‖. The 
normal balance between antioxidants and free radicals in the body is offset when either of 
these  forces  prevails.  The  available  evidence  on  the  harmful  effects  of  antioxidants  is 
analyzed in this review. In summary, a hypothesis is presented that ―antioxidant-induced 
stress‖ results when antioxidants overwhelm the body’s free radicals. 
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1. Introduction 
The  emergence  of  aerobic  organisms  was  a  consequence  of  oxygen  becoming  a  significant 
component of the earth’s atmosphere. The evolution of aerobic organisms was probably the result of 
their gradual adaptation to oxygen. Antioxidant enzymes probably facilitated part of such adaptation, 
since strict anaerobes have neither superoxide dismutase (SOD) nor catalase, whereas aerotolerant 
anaerobes have  small  levels  of those  enzymes  [1]. Aerobic  organisms use  oxygen to  produce  the 
chemical energy they need to survive. Metabolic pathways of aerobic organisms lead to the obligate 
production  of  reactive  oxygen  species  (ROS)  and  reactive  nitrogen  species  (RNS),  which  are  not 
necessarily  bad.  Indeed,  reactive  species  are  actually  needed  as  signal  transduction  elements  in 
processes  that  are  essential  for  life,  such  as  cell  growth,  differentiation,  preconditioning  and  cell  
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death  [2,3].  They  also  participate  in  functions  such  as  phagocytosis  and  stress  response  [4].  This 
echoes Barry Halliwell’s [5] ―All aspects of aerobic life involve free radicals and antioxidants—you 
cannot escape them nor should you wish to‖. 
Free radicals are molecules or atoms characterized by possessing an unpaired electron that is always 
seeking a counterpart to reside inside the parent home or in the home of the other electron. Free 
radicals can be produced during cellular processes or as a result of the interaction of free radicals, 
reactive species, or free radical-generating systems with other molecules [6,7]. Many of the ROS and 
RNS are free radicals. There are also macromolecular radicals that are formed by the effect of oxygen, 
drug-induced free radicals, irradiation or free radicals on such macromolecules as protein and lipids. 
For  example,  it  has  been  demonstrated  that  γ-irradiated  proteins  produce  electron  paramagnetic 
resonance (EPR)—detectable superoxide and huydroxyl radicals, in the presence of ferrous iron, via 
their intermediate conversion to hydroperoxydes [6]. Such macromolecular radicals lead to cellular 
dysfunction and decreased cell viability [8]. In the presence of hydrogen peroxide, aminoglutethimide 
(xenobiotic) modified myeloperoxidase, transforming this enzyme in a macromolecular free radical; a 
reaction that has been suggested to have a role in the development of drug-induced agranulocytosis and 
has been inhibited by polyunsaturated fatty acids [7]. Generation of lipid-derived free radicals was 
demonstrated, by in vivo EPR, in the livers of rats treated with the carcinogen diethylnitrosamine [9]. 
Lipid-derived  free  radicals  have  also  been  demonstrated,  through  EPR,  in  culture  cells  incubated  
with ferrous iron [10]. Free-radical modified lipids [11] and lipid-derived free radicals may play an 
important role in the development of atherosclerosis.  
According to Halliwell and Gutteridge [12] an antioxidant is ―any substance that, when present at 
low  concentrations  compared  to  those  of  an  oxidizable  substrate,  significantly  delays  or  prevents 
oxidation of that substance‖. Just as reactive species are not necessarily bad, antioxidants are not 
necessarily good. Antioxidants are a kind of matchmaker midwife trying to give or receive an electron 
to complete the other’s ―pair‖, but by making a proper pair, antioxidants can themselves become 
incomplete, and behave as free radicals; i.e., reactive and looking to pair with an unpaired electron. It 
is known that those ―reactive‖ antioxidants can be stabilized (recycled) by other antioxidants, which in 
turn become ―reactive‖ and can be recycled in a cascade of ―reactivity mitigation‖ (Figure 1). It is all a 
matter  of  equilibrium.  It  well  is  accepted  that  oxidative  stress  is  produced  when  the  equilibrium 
between reactive species and antioxidants is tilted in favor of the former. However, the equilibrium can 
be broken also if antioxidant levels exceed those of the reactive species. Dü ndar [13] proposed the 
term ―antioxidative stress‖ for such disequilibrium.  
Nature is certainly wise. Aerobic organisms mitigate reactive species not only with antioxidant 
molecules that donate or receive electrons but also through reactions catalyzed by antioxidant enzymes. 
Figure 2, below, illustrates the production of superoxide by pro-oxidant enzymes and the intervention 
of antioxidant enzymes to stabilize such free radical. Int. J. Mol. Sci. 2012, 13  2093 
 
 
Figure  1.  A  free  radical  is  a  reactive  species  because  it  has  an  unpaired  electron.  Its 
reactivity  is  mitigated  by  an  antioxidant  (A)  that  donates  an  electron  and  in  turn  is 
converted to a reactive species that is recycled by a second antioxidant (B). 
 
Figure  2.  Superoxide  radical  (O2
.−)  is  produced  from  oxygen  (O2)  at  complex  I  and 
complex III of mitochondria during respiration. It can also be produced through reactions 
catalyzed by NADPH oxidase (NADPHox) or xanthine oxidase (XO). Superoxide dismutase 
(SOD) and glutathione peroxide (GPx) catalyze the conversion by superoxide into hydrogen 
peroxide  (H2O2,  a  reactive  oxygen  species).  GPx  requires  the  oxidation  of  glutathione 
(GSH) to oxidized glutathione (GSSG), which is reduced to recycle GSH through the enzyme 
glutathione reductase (GRx). GSH could be also used in detoxification (metabolism of  
the  toxic  X  by  conjugation  with  GSH)  catalyzed  by  glutathione  S  transferase  (GST). 
Superoxide participates in the reduction of ferric iron. Hydroxyl radical (OH
.) is formed by 
the interaction of H2O2 and ferrous ion. OH
. oxidizes proteins, DNA and lipids. 
 
Figure  2  is  only  an  example  of  the  different  reactions  that  produce  reactive  species,  which 
potentially lead to oxidative stress. We have taken this very simple sequence of reactions to illustrate 
how changes can lead to oxidative stress and make a later parallel with the antioxidant-induced stress. 
Superoxide radical production can be increased if the activity of NADPHox or XO increases. Indeed, it 
has been postulated and partially shown, that oxidative stress in hypertension is due, at least in part, to 
the  increase  of  NADPHox’s  activity  in  vascular  smooth  muscle  cells,  fibroblasts  and  endothelial  
cells [14,15]. Polymorphisms of the genes codifying SOD and GPx have been related to oxidative 
stress due to decreased activity of the enzymes and high incidence of coronary artery disease [16], 
ischemic stroke [17,18] and atherosclerosis [19]. Polymorphisms of GST have been associated with 
cardiovascular events produced in smokers [20]. Int. J. Mol. Sci. 2012, 13  2094 
 
 
2. Physiological Effects of Reactive Species 
Reactive species participate in different functions and play a role as signal transduction elements in 
many physiological events. ROS and RNS participate in signal transduction of cytokine receptors, 
tyrosine receptor, serine/threonine kinases, G protein-coupled receptors, ion-channel linked receptors 
in  response  to  angiotensin  II,  cytokines,  glutamate,  epidermal  growth  factor,  vascular  endothelial 
growth factor, tumor necrosis factor α and platelet derived growth factor [2]. Free radicals and ROS 
participate in the redox regulation of activator protein 1, nuclear factor  B (NFκ-B), cyclic response 
element-binding  protein  (CREB),  nuclear  factor  E2-related  factor  2  (Nrf2)  and  p53  (―guardian  of  
the  genome‖)  [2,15].  Superoxide  and  hydrogen  peroxide  activate  extracellular  signal-related  
protein  kinase  (ERK),  protein  kinase  B,  mitogen-activated  protein  kinases  (MAPKs)  and  insulin 
receptor kinase [15,21–23]. 
The effects of reactive species are dose-dependent. Incubation of Jurkat T-cells with increasing 
concentrations of H2O2 produced proliferation (0.7 μM), apoptosis (1.0–1.3 μM) or necrosis (>3 μM) [24]. 
ROS participate in proteolysis into the proteasome. H2O2 increases proteolysis at concentrations of  
20–400 μM, whereas it inhibits proteolysis at higher, mM concentrations, producing an accumulation 
of oxidized proteins [25]. Preconditioning is one of the areas where the dose-dependent physiological 
effects of reactive species are evident. Repeated or unique application of injurious stimuli, at intensities 
below  the  threshold  of  damage,  activates  endogenous  mechanisms  that  afford  protection  when 
subsequent major injurious stimuli are applied. This phenomenon is known as preconditioning [26]. 
Hyperbaric oxygen [26], short ischemia [27–29], small doses of lipopolysaccharides [30], restraint 
stress [31], hypoxia [32], hyperthermia [32] and moderate aerobic exercise [33,34] are some of the 
stimuli producing preconditioning. We chose the example of exercise to explain the role of reactive 
species on preconditioning (see Figure 3). An excess of ROS are produced during acute or intense 
exercise [35,36]. It was thought that mitochondria were the primary site of superoxide production 
during exercise, because oxygen consumption in respiration is increased. However, it is now known 
that superoxide is produced mainly through NADPHox, XO and phospholipase A2 (PLA2) during 
intense exercise [34]. Chronic moderate exercise suppresses oxidative stress produced by acute intense 
exercise [34,35]. The mechanism of such adaptation seems to involve, as has been demonstrated in 
different studies, activation of NFκ-B by ROS and the consequent expression of nitric oxide synthases 
and antioxidant enzymes [37–39]. Indeed, the incubation of cells with hydrogen peroxide induces the 
expression of antioxidant enzymes [40].  Int. J. Mol. Sci. 2012, 13  2095 
 
 
Figure 3. Chronic exercise increases the production of superoxide radical (O2
.−) through 
the increase of mitochondrial respiration and activation of NADPH oxidase (NADPHox), 
phospholipase  A2  (PLA2)  and  xanthine  oxidase  (XO).  The  superoxide  radical  activates 
Nuclear  Factor  κ-B  (NFκ-B),  which  in  turn  produces  preconditioning  (increase  of  the 
endogenous  antioxidant  defense),  characterized  by  the  increased  gene  expression  and 
activity of superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase (CAT) and 
nitric oxide synthases (NOSs). Antioxidants interfere with the effects of chronic exercise. 
More details are in references [34–39,41–43]. 
 
3. Pro-Oxidant Effects of Antioxidants 
As mentioned above, antioxidants become ―unstable‖ and ―reactive‖ when they lose or receive 
electrons in the presence of reactive species (see Figure 1). In these conditions antioxidants exhibit 
pro-oxidant effects and can become harmful. Their redox potential (tendency to acquire electrons and 
thereby be reduced) could be related to the toxic effects of antioxidants. The redox potentials of some 
antioxidants of interest are: 0.65 V for β-carotene, 0.50 V for Vitamin E, 0.25–0.50 V for flavonoids, 
0.25 V for uric acid and 0.01 V for Vitamin C [44–46]. It has been said that a network of antioxidants 
is necessary. Antioxidants should be interconnected in such a way that they can turn off each other’s 
reactivity  after  interacting  with  reactive  species  [47].  Precisely;  Damiani  [48]  defined  a  good 
antioxidant as one that produces a low oxidant reactivity with a low capacity to produce peroxidation. 
α-tocopherol  (α-TC,  Vitamin  E)  produces  α-tocopheroxyl  radical  (α-TC
.)  when  it  reacts  with 
reactive species such as peroxynitrite [49] or superoxide [50]. α-TC
. is then recycled to α-TC by other 
antioxidants such as ascorbic acid (Vitamin C) and glutathione [48,51,52]. As soon as ascorbic acid 
recycles  Vitamin  E,  it  is  transformed  to  the  ascorbyl  radical,  which  has  a  lower  reactivity  than  
α-TC
.  [48].  α-TC
.  is  also  recycled  to  α-TC
 by  β-carotene  [52,53].  Therefore,  it  is  important  that 
Vitamin E be administered with another antioxidant. It is also important to have significant levels of 
endogenous antioxidants to allow for the recycling of ―reactive‖ antioxidants. Some conditions reduce 
endogenous antioxidants and could potentially affect the recycling of Vitamin E (or another antioxidant), 
leaving α-TC
. available to produce lipoperoxidation. One such condition is the reduction of ascorbic 
acid  in  smokers  [48,52].  Ascorbic  acid  also  recycles  oxidized  glutathione  (GSSG)  to  reduced 
glutathione (GSH)  [51], and carotenoid radicals to carotenoids [53]. Dihydro-lipoic acid (DHLA),  
the  reduced  form  of  lipoic  acid  (an  antioxidant)  recycles  GSH  from  GSSG  and  the  ascorbic  
ascorbyl radical [54].  Int. J. Mol. Sci. 2012, 13  2096 
 
 
The pro-oxidant or antioxidant effects of some antioxidants depend on their concentration. For 
example lipoic acid and DHLA inhibit nitro-tyrosine formation by peroxynitrite at a 0.01–0.05 mM 
concentration, whereas promote mitochondrial permeability transition at 0.1 mM, increase of glucose 
intake at 0.25 M, and stimulate calcium mitochondria release at 1 mM.  β-carotene protects DNA 
oxidative damage at 1–3 μM, whereas it oxidizes DNA at 4–10 μM. High concentrations of β-carotene 
inhibit the growth of cancer cells in culture and promote their apoptosis [53]. 
Some antioxidants exhibit pro-oxidant activities in the presence of transition metals. Such is the 
case of ascorbic acid that is transformed into an ascorbyl radical [55] and hydroxycinnamic acid whose 
phenolic groups are transformed into phenoxy reactive groups [56]. Retinal and carotenoid radical are 
produced by the oxidative cleavage of β-carotene in the presence of oxygen and ferrous ion [57,58]. 
Oxidative cleavage of β-carotene is also produced by many other oxidative stimuli: ultraviolet light 
(artificial and sun light), heat, free radicals, and ozone [59]. Carotenoid breakdown products (CBP) 
were  produced  in  ferrets  by  cigarette  smoke  exposure.  The  effect  was  prevented  by  α-TC  and  
ascorbic acid [52].  
Reactive species produced by the interaction of an antioxidant with a free radical such as ROS or 
RNS exhibit potentially toxic pro-oxidant effects. CBP inhibit mitochondrial respiration in the rat lung, 
brain  and  liver  [59],  stimulate  apoptosis  in  neutrophils  [59],  oxidize  DNA  [60]  and  up-regulate 
advanced glycation endproducts [53]. 
In  summary,  the  pro-oxidant  and  potential  harmful  effects  of  an  antioxidant  depend  on  (a)  its 
concentration;  (b)  its  redox  potential;  (c)  the  presence  of  other  antioxidants;  (d)  the  presence  of 
transition metals, (e) the activity and concentrations of endogenous antioxidants. And, even though not 
yet demonstrated, the genetic background could also contribute to the harmful effects of antioxidants. 
Some of these factors are further considered in the following section. 
4. Clinical Trials with Antioxidants 
The validity of antioxidant therapy has been questioned, having been pointed out that even though 
several diseases have been related to oxidative stress, antioxidant therapy does not change the natural 
course of diseases [5,47,61–64]. Some authors have commented that antioxidant therapy has only been 
validated in experimental models of disease and cell culture [5,61]. However, different factors cause 
artifacts in cell culture (e.g., high oxygen levels compared to the pO2 of tissues in the organism, 
components of the cell culture media, high concentrations of antioxidants) [5,61]. In the clinical arena 
one of the problems is the biomarkers to evaluate oxidative stress [63]. It has been postulated that a 
combination of low doses of antioxidants could only be useful in patients suffering from antioxidant 
deficiencies [63]. It remains unknown if patients with gene polymorphisms affecting the structure and 
function of antioxidant enzymes could have different responses to antioxidants.  
What is interesting is that when no effects or negative results of antioxidants are reported, there is 
often an alternate conclusion that antioxidants can be dangerous. For example: the method used to 
evaluate oxidative stress, treatment strategy (preventive strategy, doses, combination of antioxidants, 
duration), the stage of the disease, the follow up period, and number of patients [65]. Interestingly, in a 
recent review, Ristow and Schmeisser [66] suggest that life span could be extended by oxidative stress. 
A summary of clinical trials with antioxidants, as well as possible explanations are shown below.  Int. J. Mol. Sci. 2012, 13  2097 
 
 
4.1. Beneficial Effects of Antioxidants 
Nurses’ Health Study (NHS). This was a cohort study of more than 87,000 U.S. nurses, ages 34–59, 
with no history of cardiovascular disease (CVD). Follow up period: 8 years. Results: Supplemental 
Vitamin E (at least 100 IU/day, for at least 2 years) was associated with reductions of 40% or more in 
the risk of coronary heart disease (CHD) [67,68].  
Health  Professional  Follow  up  Study  (HPFS).  This  was  an  observational  study  of  around  
40,000 U.S. male health professionals, ages 50–75, with no CHD, diabetes or hypercholesterolemia. 
Supplemental Vitamin E (at least 100 IU/day, for at least 2 years) was associated with a significant 
reduction of CHD risk [67,69].  
The ―Established Populations for Epidemiologic Studies of the Elderly‖ program. This involved 
11,178 U.S. men and women, ages 67–105. Results: There is a significant decreased risk of CHD 
mortality among those taking vitamin supplements [67,70]. 
The  first  National  Health  and  Nutrition  Examination  Survey  (NHANES  I).  This  involved  
11,348 U.S. women and men, ages 25–74. Conclusion: Vitamin C intake was inversely associated with 
all causes of mortality and CVD in men, but not in women [71]. 
Scottish Heart Health study. This involved 3833 women and 4036 men, ages 40–59, with no heart 
disease at the beginning of the study. Vitamin C and -carotene intake were associated with reduced 
CHD, only in men [71,72]. 
In a recent meta-analysis Myung et al. [73] evaluated 22 case-control reports (from 274 articles), 
including 10,073 patients with a cervical neoplasm risk. They found preventive effects of Vitamins B12, 
C, E and β-carotene on cervical neoplasms.  
Alpha tocopherol, Beta carotene cancer prevention study (ATBC). This involved 27,111 Finnish 
male smokers, ages 50–69. Follow up: 16–19.4 years. Results: A higher αTC intake was associated 
with a lower pancreatic [74] and prostate [75] cancer risk. In the same study high flavonoid intake was 
also related to lower pancreatic cancer risk [76]. 
4.2. Antioxidants Do not Change the Evolution of Diseases Related to Oxidative Stress  
20,536  patients  with  hypertension  at  high  cardiovascular  risk  were  followed  for  five  years. 
Treatment with ascorbic acid, Vitamin E and β-carotene neither reduced blood pressure nor changed 
mortality or morbidity [14,77]. 
Rotterdam study. This involved  4,802 Dutch  men  and  women,  ages 55–95, with no history of 
myocardial infarction (MI). Follow up: After 4 years, no association was observed between Vitamin E 
intake and the risk of MI [71,78]. 
Scottish Heart Health Study (see above). No protection was associated with Vitamin E. Vitamins C, 
E and -carotene had no effect on all-cause mortality [71]. 
Heart Protection Study. This included 20,536 men and women with CHD or diabetes, ages 40–80. 
Follow  up:  After  5  years,  the  intake  of  Vitamin  E  (600  mg/day),  Vitamin  C  (250  mg/day)  and  
-carotene (20 mg/day) had no effect [71]. 
Primary Prevention Project. This program involved 4,495 men and women, with an average age of 
64 and at least one risk factor for CHD, who took a low dose of aspirin (100 mg/day) and Vitamin E Int. J. Mol. Sci. 2012, 13  2098 
 
 
(300 mg/day). The study was stopped early because other trials had demonstrated protection with 
aspirin. Vitamin E had no effect [71]. 
Heart  Outcomes  Prevention  Evaluation  Study  (HOPES).  This  included  2545  women  and  
6999 men, ≥55, with CHD or diabetes and one risk factor for atherosclerosis. They received Vitamin E 
(400 IU/day) or a placebo, angiotensin-converting enzyme inhibitor or a placebo. A follow up after  
4.5 years indicated that Vitamin E had no effect [71,79]. 
Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI). This included 
11,324 Italian men and women who had survived a myocardial infarction within the 3 previous months. 
They  received  Omega-3  oils  (1  g/day)  and/or  Vitamin  E  or  no  treatment.  A  follow  up  after  
3–5 years showed that Vitamin E had no effect [71,80].  
Rytter et al. [81] studied 40 patients with type 2 diabetes, who were randomly assigned to one of 
two groups, one treated with antioxidants extracted from fruits, berries and vegetables (tocopherols, 
carotenoids and ascorbate), and the other treated with placebo. The authors found that 12 weeks of 
treatment did not change the metabolic profile, neither oxidative nor inflammatory biomarkers, even 
though antioxidant systemic levels had increased. Recently, Suksomboon et al. [82] analyzed 9 trials 
including 418 type 2 diabetic patients who were treated with Vitamin E for 8 weeks. They found that 
Vitamin  E  did  not  improve  glycemic  control  unless  the  patients  began  their  treatment  under  bad 
metabolic control and with a Vitamin E deficiency.  
Arain et al. [83] analyzed four clinical trials to evaluate the effects of Vitamin E on colorectal 
cancer. The trials included 94,069 patients (47,029 received Vitamin E) and had a follow up period of 
4 years. The authors concluded that Vitamin E had no effect on colorectal cancer. 
4.3. Harmful Effects of Antioxidants 
We summarize here some of the published studies that show the harmful effects of antioxidant 
supplements in humans.  
In a study made in Australia, 69 hypertensive patients with an ambulatory systolic pressure of  
>125 mmHg received treatment with Vitamin C (500 mg/day) and grape seed polyphenols (1000 mg/day) 
for 6 weeks. At the end of the treatment their systolic and diastolic pressures increased and there were 
no changes in their endothelium dependent vasodilation or oxidative stress biomarkers  [84]. HDL 
Atherosclerosis  Treatment  Study  (HATS).  160  men  (<70)  and  women  (<63),  with  low  HDL  and 
triglycerides <400 mg/dL. Patients were assigned to one of 4 groups: Simvastatin + niacin with or 
without Vitamin E (800 IU/day), Vitamin C (1000 mg/day),  carotene (25 mg/day) and selenium  
(100 μg/day); Antioxidants or placebo. A follow up after 3 years showed that antioxidant treatment 
blunted HDL elevation produced by simvastatin + niacin [71,85].  
The Prostate, Lung, Colorectal and Ovarian cancer Screening Trial (PLCO) was a prospective study 
of 25,400 postmenopausal U.S. women, ages 55–74, who were followed for 10 years. The results 
showed that the risk of breast cancer increased significantly (by 20%) in women who had a folic acid 
supplement (≥400 μg/day) whereas food folate intake was not associated with an increased risk [86]. 
Beta carotene and Retinal Efficacy Trial (CARET). This involved 18,314 U.S. women and men on  
β carotene (30 mg/day) and Vitamin A (25,000 IU/day) or a placebo. The study had to be stopped two 
years prematurely because Vitamin-treatment was associated with a 28% greater incidence of lung Int. J. Mol. Sci. 2012, 13  2099 
 
 
cancer and 17% more deaths than placebo treatment [71,87]. Alpha Tocopherol Beta Carotene Cancer 
Prevention Study (ATBC). This covered 29,133 male smokers, ages 50–69, taking α-TC (50 mg/day) 
and/or  β-carotene  (30  mg/day).  There  was  an  8%  greater  mortality  in  those  men  taking  the 
supplements  than  the  men  treated  with  the  placebo  [71,88,89].  Bjelakovic  et  al.  [90]  published  a  
meta-analysis of antioxidant supplements for the prevention of gastrointestinal cancer. They selected  
7 high quality randomized trials (of the 14 trials examined), including 131,727 patients. They found 
that antioxidants significantly increased overall mortality and did not prevent gastrointestinal cancer. 
Myung et al. [91] analyzed 31 of 3,327 articles searched, including 22 trials with 161,045 patients 
(88,610 treated with antioxidants). The authors concluded that antioxidants had no preventive effects 
on cancer. However, when they evaluated a subgroup of four controlled trials they found that patients 
receiving antioxidants had a significant increase in bladder cancer.  
Antioxidants Vitamin C (12.5 mg/Kg) and N-acetylcysteine (10 mg/Kg) significantly increased the 
oxidative  stress  produced  by  acute  exercise  in  healthy  subjects.  The  effect  was  attributed  to  the 
conversion of ascorbic acid into the ascorbyl radical by reactive species generated during exercise [41]. 
Ristow  et  al.  studied  insulin  sensitivity,  transcriptional  regulators  of  insulin  sensitivity  and  gene 
expression of SODs, GPx and catalase in 19 trained and 20 untrained healthy young men who were 
treated with Vitamin E (400 IU/day) + Vitamin C (1000 mg/day) or placebo, and were trained for four 
weeks. They found that exercise increased insulin sensitivity as well as the gene expression of insulin 
sensitivity transcriptional regulators and antioxidant enzymes. The effects of exercise were blocked by 
antioxidant supplements [42]. Recently, Peternelj and Combes [43] evaluated 23 studies that reported 
negative effects of antioxidant supplements on the beneficial effects produced by chronic exercise. 
They  found  that  antioxidants  interfere  with  vasodilation  and  increased  insulin  signaling  produced  
by exercise. 
Recently,  the  Iowa  Women’s  Health  Study  results  were  published  [92].  The  study  included  
38,772  women,  who  were  older  than  60  in  1986.  Vitamin  and  mineral  supplement  intake  was  
self-reported at different periods. The authors concluded that dietary Vitamin and mineral supplements 
may be associated with increased mortality, with the effect being worse when the supplements were 
accompanied by an iron supplement.  
Table 1. Clinical trials with antioxidants. 
Studies reporting beneficial effects of antioxidants 
Study  N  Age (years) 
Follow up 
period 
Antioxidant  Main Outcome  References 
Nurses’ Health 
Study (NHS) 
87,245  34–59  8 years  Vitamin E 
Significant reduction 
in CHD risk 
[67,68] 
Health Professional 
Follow up Study 
(HPFS) 
39,910  40–75  4 years  Vitamin E 
Significant reduction 
in CHD risk 
[67,69] 
Established 
Populations for 
Epidemiological 
Studies of the Elderly 
11,178  67–105  6 years 
Vitamin E 
with or 
without other 
Vitamins 
Vitamin E associated 
with a significant 
reduction CHD risk 
[67,70] Int. J. Mol. Sci. 2012, 13  2100 
 
 
Table 1. Cont. 
Studies reporting beneficial effects of antioxidants 
Study  N  Age (years) 
Follow up 
period 
Antioxidant  Main Outcome  References 
First National 
Health and Nutrition 
Examination Survey 
(NHANES I) 
11,348  25–74  10 years  Vitamin C 
Inverse correlation 
between Vitamin C 
and all-cause CVD 
death in men; not 
women 
[71] 
Scottish Heart 
Health Study 
7869  40–59  10 years 
Vitamins C, E 
and β-carotene 
Significant reduction 
of CHD; only in men 
[71,72] 
Meta-analysis  10,073  18–90  NR 
Vitamins C, E 
and B12, and  
β-carotene 
Preventive effects on 
cervical neoplasms 
[73] 
Alpha-Tocopherol, 
Beta carotene 
Cancer Prevention 
Study (ATBC) 
27,111  50–69 
16–19.4 
years 
Alpha-
tocopherol,  
β-carotene and 
flavonoids 
Alpha-tocopherol 
was associated with 
reduced risk of 
pancreatic and 
prostate cancer. 
Flavonoids were 
associated with 
decreased risk of 
pancreatic cancer 
[74–76] 
Heart Protection 
Study 
20,536  40–80  5 years 
Vitamins C 
and E and  
β-carotene 
No reductions in 
blood pressure, 
morbidity or 
mortality 
[14,77] 
Rotterdam Study  4802  55–95  4 years 
Vitamins C 
and E and β 
carotene 
No effects of Vitamin 
E on the risk of 
myocardial infarction 
[71,78] 
Scottish Heart 
Health Study 
7869  40–59  10 years 
Vitamins C 
and E and  
-carotene 
No effects on  
all-cause mortality 
[71,72] 
Primary Prevention 
Project 
4495  64 (average)  3.6 years 
Vitamin E and 
low-dose 
aspirin 
Vitamin E had no 
beneficial effect. 
Trial terminated 
because other studies 
demonstrated the 
beneficial effect of 
aspirin on 
cardiovascular 
mortality 
[71] 
Heart Outcomes 
Prevention 
Evaluation Study 
(HOPE) 
9544  >55  4.5 years  Vitamin E 
No effect of  
Vitamin E 
[71,79] Int. J. Mol. Sci. 2012, 13  2101 
 
 
Table 1. Cont. 
Studies reporting no effect of antioxidants 
Study  N  Age (years) 
Follow up 
period 
Antioxidant  Main Outcome  References 
Gruppo Italiano per 
lo Studio della 
Supravvivenza nell’ 
Infarto Miocardico 
(GISSI) 
11,324 
59.3 
(average) 
3.5 years 
Vitamin E and 
omega-3 oils 
No effect of  
Vitamin E 
[71,80] 
Study on well 
controlled diabetic 
patients 
40  61.9  12 weeks 
Extracts of 
fruits and 
vegetables 
No effect of the 
extracts 
[81] 
Meta-analysis 
including studies 
performed in Type 2 
diabetic patients 
418  20–80  8 weeks  Vitamin E 
No effects on 
metabolic control 
[82] 
Meta-analysis  94,069  >49  7–10 years  Vitamin E 
No effect on 
colorectal cancer 
[83] 
Randomized, double 
blind, placebo 
controlled study in 
hypertensive 
patients 
69  62 (average)  6 weeks 
Vitamin C and 
grape seed 
polyphenols 
Increase of blood 
pressure and no effect 
on either endothelium 
dependent 
vasodilation or 
oxidative stress 
[84] 
Randomized study 
in patients with 
CAD 
169  52 (average)  3 years 
One statin, 
Vitamin C, 
vitamin E,  
β-carotene and 
selenium 
Antioxidants blunted 
the effect of statins 
on HDL 
[71,85] 
Prostate, Lung, 
Colorectal and 
Ovarian Cancer 
Screening Trial 
(PLCO) 
25,400  55–74  10 years  Folic acid 
Folic acid 
supplementation 
significantly 
increased breast 
cancer 
[86] 
Beta Carotene and 
Retinal Efficacy 
Trial (CARET) 
18,314  58 (average) 
Stopped 
after 2 
years 
Vitamin A and 
β-carotene 
Antioxidant treatment 
was associated with an 
increased incidence of 
lung cancer and 
mortality 
[71,87] 
Alpha- Tocopherol 
Beta-Carotene 
Cancer Prevention 
Study (ATBC) 
29,133  50–69  8 years 
α-tocopherol, 
β-carotene 
Antioxidants increased 
the incidence and 
mortality of lung 
cancer 
[88,89] Int. J. Mol. Sci. 2012, 13  2102 
 
 
Table 1. Cont. 
Studies reporting harmful effects of antioxidants 
Study  N  Age (years) 
Follow up 
period 
Antioxidant  Main Outcome  References 
Meta-analysis  131,727  55 (average)  1–12 years 
β-carotene, 
Vitamin A, 
Vitamin E, 
selenium 
The antioxidant 
treatment did not 
prevent gastrointestinal 
cancer but significantly 
increased mortality 
[90] 
Meta-analysis  161,045 
58.4 
(average) 
5.3–5.8 
years 
β-carotene, 
Vitamin C, 
Vitamin E, 
selenium 
Increased risk of 
bladder cancer in 4 of 
22 of the trials included 
in the analysis 
[91] 
Study in healthy 
men 
14 
24.4 
(average) 
7 days 
Vitamin C  
and N-
Acetylcysteine 
Increase of oxidative 
stress produced by 
exercise 
[41] 
Study in healthy 
men 
39  25–35  4 weeks 
Vitamin C and 
Vitamin E 
Antioxidants blocked 
the increase of 
insulin sensitivity 
and expression 
produced by exercise 
[42] 
Meta-analysis  338 *  NR 
1 day– 
6 weeks 
Allopurinol, 
Coenzyme Q, 
Vitamins  
(C, E, B6, B12), 
α-lipoic acid, 
β- carotene, 
lutein, N-
acetylcysteine, 
Selenium 
and/or Zinc 
Any of these effects 
(compared to groups 
treated with placebo): 
 training induced 
improvement in 
physical performance, 
 exercise-induced 
oxidative stress 
preconditioning,  
CK,  inflammatory 
biomarkers, prevented 
beneficial effects on 
insulin sensitivity and 
expression 
[43] 
Iowa Woman’s 
Health Study 
38,772  >60  14 years 
Dietary 
vitamins and 
mineral 
supplements 
May be associated 
with increased total 
mortality risk 
[92] 
CAD = Coronary artery disease, CHD = Coronary heart disease, CK = creatine kinase, CVD = Cardiovascular 
disease,  HDL  =  high  density  lipoproteins,  NR  =  not  reported.  *  Includes  34  from  Childs’  [41]  and  
Ristow’s [66] studies. 
Table 1 summarizes the results of the clinical trials described above. Some data command attention. 
The total number of study patients reporting beneficial antioxidant effects is 194,734 whereas those 
reporting no, or harmful effects is 554,083 (149,097 and 404,986, respectively). After comparing the Int. J. Mol. Sci. 2012, 13  2103 
 
 
trials, it can be concluded that the results probably depended on the population studied (age, gender, 
health  conditions,  ethnicity),  antioxidants  (type,  combinations,  supplements  or  dietary),  follow-up 
period, and specific outcome. For instance, comparing the NHS study (beneficial effects) [68], with the 
Iowa Woman’s Health Study (IWHS, harmful effects) [92], it is seen that, even though the number of 
participants (all women) is higher in the NHS study (more than double the IWHS), there are significant 
differences: participants in the NHS study were younger, the follow up period was shorter in the  
NHS study, the focus of the NHS study was vitamin E whereas the IWHS examined the effect of 
supplement and dietary vitamin/mineral, outcome in the NHS study was only cardiac heart disease, 
whereas outcome in the IWHS was mortality.  
Similarly,  comparing  the  HPFS  study  (beneficial  effects)  [69]  with  the  ATBC  study  (harmful 
effects)  [89],  there  are  differences  that  may  have  influenced  the  results.  The  HPFS  study  was 
performed in healthy men, whereas the ATBC study was run with male smokers. The HPFS study 
examined the effect of Vitamin E; the ATBC study analyzed the effect of Vitamin E and -carotene. 
The follow-up period was shorter in the HPFS study and the reported outcome was different: i.e., risk 
of CHD in the HPFS study vs. lung cancer and mortality in the ATBC study. Therefore, the main 
differences between the HPFS and ATBC studies are the particular conditions of the participants and 
the  antioxidants  related  to  the  results.  It  is  known  that  smoking  produces  oxidative  stress  and  
cancer [93,94]; and also known, as mentioned above, that an antioxidant is converted to a reactive 
species when it interacts with a free radical (Figure 1). A second antioxidant, by reacting with the 
―activated‖ antioxidant, can mitigate its free radical effects and recycle it as an antioxidant. These 
could explain the results of the ATBC study. Vitamin E alone did not produce any change, but the 
incidence of lung cancer and mortality increased in those participants who received Vitamin E and  
-carotene [89]. Moreover, the CARET study, that looked for effects of Vitamin A and -carotene in 
women and men who had worked with asbestos or were smokers [87] (both conditions are related to 
cancer),  had  to  be  stopped  prematurely  because  of  the  clear  correlation  of  increased  lung  cancer 
incidence and mortality. It can be postulated that β-carotene, in the presence of severe oxidatively 
damaged of DNA, could contribute to genomic changes leading to cancer. Interestingly, β-carotene is 
one of the antioxidants with the highest redox potential [46]. This characteristic could be related to the 
potential toxic effect of β-carotene in the presence of severe OS. A high redox potential could make  
-carotene  more  capable  of  oxidizing  molecules.  Indeed,  high  concentrations  of  β-carotene  itself 
oxidize  DNA  [53].  It  has  been  postulated  that  smoke  carcinogens  alter  carotenoid  metabolism, 
contributing to the effects of DNA mutation and proliferation [95].  
Another  mechanism  that  seems  to  affect  the  final  result  of  antioxidant  supplementation  is  the 
normal responses of the organism to OS. In the first part of this review, it was mentioned that acute 
exercise produces OS [34–39]. Chronic exercise reduces the OS produced during acute exercise by 
activating NF-B, which leads to gene expression of antioxidant enzymes, and NOSs [37–39]. The 
phenomenon  is  termed  ―preconditioning‖.  It  has  been  postulated  that  antioxidant  supplements,  by 
blocking free radicals and therefore the signal-transduction pathways that they activate during chronic 
exercise, inhibit such preconditioning [42,43] (see Figure 3). Int. J. Mol. Sci. 2012, 13  2104 
 
 
5. Conclusions  
Even though antioxidants have been considered beneficial, a number of clinical trials have shown 
harmful  effects.  The  most  extreme  results  evidenced  increased  mortality  in  individuals  taking 
antioxidant supplements. Although the mechanisms are not explained in those trials, the results suggest 
that disrupting the delicate balance between antioxidants and reactive species produces antioxidant-induced 
stress, if the antioxidants overwhelm the physiological production of reactive species. 
Though these conclusions remain speculative, the best advice would be to ingest antioxidants from 
food sources rather than from self-prescribed supplements. The most probable way of increasing the 
endogenous antioxidant defense would be by practicing moderate aerobic exercise, as an every day 
healthy routine. Gene polymorphisms, which condition endogenous antioxidant deficiencies, would be 
the exception to such advice. 
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